At ATEM we believe that industrial cryo-EM is still in its infancy. To utilize the technology’s full potential in drug discovery and R&D we are building a uniquely integrated platform to meet today’s and future commercial demands.
Dr. Karl Bertram completed his PhD and postdoctoral position at the Max Planck Institute for Biophysical Chemistry, where he focused on the 3D structures of human spliceosomes. With his strong background in cryo-EM, he co-founded ATEM, providing his knowledge to develop an entirely novel cryo-EM platform.
Daniel Winkler graduated from WHU Otto Beisheim School of Management with a degree in Business Administration. After years of accumulated business and finance expertise, he continued to expand his ideas and formed ATEM together with Dr. Karl Bertram.